Investors are responding positively to Meta’s decision to keep increasing artificial intelligence spending, even as fears grow…
LIXTE Biotechnology recently acquired Liora Technologies, and the acquisition includes Liora’s proprietary LiGHT system This…
LIXTE’s lead compound, LB-100, targets PP2A, a central regulator of cancer cell survival and treatment…
Although cancer immunotherapy has transformed treatment for many patients, the promise of effective immunotherapy falls short for many…
Power availability and control are emerging as binding constraints on AI data center growth, with…
ParaZero entered the Cyprus market via a reseller agreement with homeland security specialist Lella Kentonis…